Inventor
TANG GUOZHI
CN15 patents
⚠️ This page may combine multiple inventors who share the name “TANG GUOZHI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
6 patentsUS9447086B2Sep 20, 2016
6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE34 citations93
US10669268B2Jun 2, 2020
Bicyclic derivatives
HOFFMANN LA ROCHE9 citations83
US10913745B2Feb 9, 2021
Octahydro-pyrrolo[3,4-c]-pyrrole derivatives and analogs thereof as autotaxin inhibitors
HOFFMANN LA ROCHE3 citations72
US7977372B2Jul 12, 2011
Ortho aminoamides for the treatment of cancer
HOFFMANN LA ROCHE0 citations49
US9856247B2Jan 2, 2018
4-methyl-dihydropyrimidines for the treatment and prophylaxis of Hepatitis B virus infection
HOFFMANN LA ROCHE0 citations39
US10597380B2Mar 24, 2020
Pyridazinone-based broad spectrum anti-influenza inhibitors
HOFFMANN LA ROCHE0 citations38
ASCENTAGE PHARMA SUZHOU CO LTD
5 patentsUS11691989B2Jul 4, 2023
Macrocyclic indoles as Mcl-1 inhibitors
ASCENTAGE PHARMA SUZHOU CO LTD3 citations71
US11312724B2Apr 26, 2022
Spirocyclic tetrahydroquinazolines
ASCENTAGE PHARMA SUZHOU CO LTD4 citations69
US12319703B2Jun 3, 2025
Macrocyclic fused pyrazoles as Mcl-1 inhibitors
ASCENTAGE PHARMA SUZHOU CO LTD0 citations47
US11987575B2May 21, 2024
Tricyclic compounds as BCR-ABL inhibitors
ASCENTAGE PHARMA SUZHOU CO LTD0 citations47
US11498928B2Nov 15, 2022
Macrocyclic spiroethers as Mcl-1 inhibitors
ASCENTAGE PHARMA SUZHOU CO LTD0 citations45